JP2025513774A5 - - Google Patents
Info
- Publication number
- JP2025513774A5 JP2025513774A5 JP2024558381A JP2024558381A JP2025513774A5 JP 2025513774 A5 JP2025513774 A5 JP 2025513774A5 JP 2024558381 A JP2024558381 A JP 2024558381A JP 2024558381 A JP2024558381 A JP 2024558381A JP 2025513774 A5 JP2025513774 A5 JP 2025513774A5
- Authority
- JP
- Japan
- Prior art keywords
- xrpd pattern
- peaks
- pattern obtained
- cukα radiation
- crystal morphology
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263327659P | 2022-04-05 | 2022-04-05 | |
| US63/327,659 | 2022-04-05 | ||
| PCT/US2023/017504 WO2023196360A1 (en) | 2022-04-05 | 2023-04-05 | Salt forms and solvates of mci-1 antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025513774A JP2025513774A (ja) | 2025-04-30 |
| JP2025513774A5 true JP2025513774A5 (enExample) | 2026-04-10 |
Family
ID=86386785
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024558381A Pending JP2025513774A (ja) | 2022-04-05 | 2023-04-05 | Ｍｃｌ－１アンタゴニストの塩形態及び溶媒和物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12351588B2 (enExample) |
| EP (1) | EP4504737A1 (enExample) |
| JP (1) | JP2025513774A (enExample) |
| AU (1) | AU2023249146A1 (enExample) |
| CA (1) | CA3254998A1 (enExample) |
| MX (1) | MX2024012192A (enExample) |
| TW (1) | TW202404983A (enExample) |
| UY (1) | UY40217A (enExample) |
| WO (1) | WO2023196360A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4519271A1 (en) | 2022-05-04 | 2025-03-12 | Gilead Sciences, Inc. | Salts and polymorphs of certain mcl-1 inhibitors |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3474B1 (ar) | 2014-08-29 | 2020-07-05 | Amgen Inc | مشتقات تيتراهيدرونافثالين التي تثبط بروتين mcl-1 |
-
2023
- 2023-04-05 JP JP2024558381A patent/JP2025513774A/ja active Pending
- 2023-04-05 EP EP23724438.9A patent/EP4504737A1/en active Pending
- 2023-04-05 WO PCT/US2023/017504 patent/WO2023196360A1/en not_active Ceased
- 2023-04-05 CA CA3254998A patent/CA3254998A1/en active Pending
- 2023-04-05 US US18/296,215 patent/US12351588B2/en active Active
- 2023-04-05 AU AU2023249146A patent/AU2023249146A1/en active Pending
- 2023-04-06 TW TW112112762A patent/TW202404983A/zh unknown
- 2023-04-10 UY UY0001040217A patent/UY40217A/es unknown
-
2024
- 2024-10-02 MX MX2024012192A patent/MX2024012192A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3164130B1 (en) | Heteroaryl compounds useful as inhibitors of sumo activating enzyme | |
| JP2024001023A5 (enExample) | ||
| JP2022049005A5 (enExample) | ||
| JP2023554492A5 (enExample) | ||
| JP2021535111A5 (enExample) | ||
| AU2011236933A1 (en) | Cephem compound having catechol group | |
| JP2022507251A5 (enExample) | ||
| JP2025513774A5 (enExample) | ||
| JP2023519891A5 (enExample) | ||
| JP2024534014A5 (enExample) | ||
| JP2012516344A5 (enExample) | ||
| JP2022511800A5 (enExample) | ||
| JP2013538849A5 (enExample) | ||
| HK1252449A1 (zh) | 突变的异柠檬酸脱氢酶idh1 r132h的抑制剂 | |
| JP2022526438A5 (enExample) | ||
| KR102612379B1 (ko) | 벤조푸란 유도체 자유 염기의 결정 및 제조 방법 | |
| JP2023027066A5 (enExample) | ||
| ZA200209558B (en) | 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3'] bipyridinyl in pure crystalline form and process for synthesis. | |
| JP2024103495A5 (enExample) | ||
| JP2022534788A5 (enExample) | ||
| JP2024095561A5 (enExample) | ||
| JPWO2021033729A5 (enExample) | ||
| JP2024539631A5 (enExample) | ||
| JP2025511331A5 (enExample) | ||
| JP2023524518A5 (enExample) |